[
    "{\"step_by_step_thinking\": \"To determine if Sotrovimab is effective for COVID-19, we need to review the available evidence. Sotrovimab is a monoclonal antibody therapy that has been authorized for emergency use by the FDA for the treatment of mild to moderate COVID-19 in certain high-risk individuals. The authorization was based on clinical trial data that showed Sotrovimab reduced the risk of hospitalization or death in these patients. Therefore, based on the available evidence, the answer is A. yes, Sotrovimab is effective for COVID-19.\", \"answer_choice\": \"A\"}"
]